AACR Gertrude B. Elion Cancer Research Award
The AACR Gertrude B. Elion Cancer Research Award, supported by GlaxoSmithKline, provides one-year grants to support tenure-eligible junior faculty conducting research in cancer etiology, diagnosis, treatment, or prevention. Research may be basic, translational, or clinical in nature.
Eligibility Criteria
-
Hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field.
-
Hold a tenure-eligible appointment at the rank of assistant professor (not research-track, adjunct, visiting, or instructor appointments).
-
Started first independent faculty position within the past six years (after November 1, 2019).
-
Applicants with a medical degree must have completed their most recent doctoral degree or residency within the past six years.
-
Must have independent laboratory space.
-
Open to applicants working at academic, medical, or research institutions worldwide.
-
AACR membership is required by the Letter of Intent deadline.
Funding Details
-
Total Award: 225,000 USD
-
Duration: 1 year
-
Eligible expenses include salary, research staff, supplies, equipment, travel, and publication charges.
Key Deadlines
-
Letter of Intent Deadline: June 3, 2025, by 1:00 PM (ET)
-
Letter of Intent Notification: August 2025
-
Full Application Deadline: September 15, 2025, by 1:00 PM (ET)
-
Funding Start Date: November 1, 2025
Further Information
For full program details, eligibility requirements, and application instructions, visit: AACR Gertrude B. Elion Cancer Research Award – ProposalCentral
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023